NUPR1 and cancer: However, studies carried out with previous compounds (TFP, ZZW-115 and its first series of derivatives) on NUPR1-deficient mice did not result in the inhibition of cancer growth [25,26], suggesting that the main target for these drugs is in fact NUPR1.